CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- FinancialsAltman Z-Score 5.38: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.52BCNY375.19M · vs all stocks (USD)
Trailing P/E
72.67xvs Diagnostics & Research peers
Revenue (TTM)
324.73MCNY48.29M · vs all stocks (USD)
Profit Margin
11.80%vs Diagnostics & Research peers
Beta
0.0660xvs all stocks
52-Week Change
-28.03%vs all stocks
Market Capitalization
2.52BCNY375.19M · vs all stocks (USD)
Enterprise Value
2.29BCNY340.60M · vs all stocks (USD)
Trailing P/E
72.67xvs Diagnostics & Research peers
Price to Sales (TTM)
8.08xvs Diagnostics & Research peers
Price to Book (MRQ)
1.82xvs Diagnostics & Research peers
Enterprise to Revenue
7.05xvs Diagnostics & Research peers
Enterprise to EBITDA
31.35xvs Diagnostics & Research peers
Gross Margin
61.48%vs Diagnostics & Research peers
Profit Margin
11.80%vs Diagnostics & Research peers
Operating Margin
9.71%vs Diagnostics & Research peers
Return on Assets (TTM)
0.92%vs Diagnostics & Research peers
Return on Equity (TTM)
2.69%vs Diagnostics & Research peers
Revenue (TTM)
324.73MCNY48.29M · vs all stocks (USD)
Revenue per Share (TTM)
0.7730CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-9.80%vs Diagnostics & Research peers
Gross Profit (TTM)
204.31MCNY30.38M · vs all stocks (USD)
EBITDA (TTM)
55.46MCNY8.25M · vs all stocks (USD)
Net Income (TTM)
38.33MCNY5.70M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-38.40%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
103.13MCNY15.34M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-171.90MCNY-25.56M · vs all stocks (USD)
Payout Ratio
138.89%vs Diagnostics & Research peers
Revenue
332.68MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
111.52MCNYFY2025 · Dec 31, 2025Gross Profit
221.16MCNYFY2025 · Dec 31, 2025Operating Income
46.55MCNY6.92M · vs all stocks (USD)
Pre-tax Income
49.82MCNYFY2025 · Dec 31, 2025Income Tax Expense
5.91MCNYFY2025 · Dec 31, 2025Net Income
43.91MCNYFY2025 · Dec 31, 2025EBIT
56.23MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
121.78MCNYFY2025 · Dec 31, 2025Research & Development
73.31MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
29.15MCNYFY2025 · Dec 31, 2025Other Operating Expenses
6.20MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
9.96MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
6.41MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1100CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
399.20MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
399.20MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
43.91MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
45.46MCNYFY2025 · Dec 31, 2025Free Cash Flow
-24.05MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
56.98MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
43.91MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.22MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
9.35MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-11.01MCNYFY2025 · Dec 31, 2025Capital Expenditures
-69.51MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.47BCNYFY2025 · Dec 31, 2025Sale of Investments
1.45BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-86.14MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-20.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-54.79MCNYFY2025 · Dec 31, 2025Other Financing Charges
-23.51MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-98.30MCNYFY2025 · Dec 31, 2025Shares Outstanding
401.11MSharesUpdated Aug 21, 2026Float Shares
230.77MSharesUpdated Aug 21, 2026% Held by Insiders
45.15%vs all stocks
% Held by Institutions
11.15%vs all stocks
Total Cash (MRQ)
388.70MCNY57.80M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.9850CNYUpdated Aug 21, 2026Total Debt (MRQ)
232.62MCNY34.59M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1638xvs Diagnostics & Research peers
Current Ratio (MRQ)
4.77xvs Diagnostics & Research peers
Book Value per Share (MRQ)
3.60CNYUpdated Aug 21, 2026Total Assets
1.76BCNY261.87M · vs all stocks (USD)
Total Current Assets
761.59MCNYFY2025 · Dec 31, 2025Total Liabilities
350.05MCNYFY2025 · Dec 31, 2025Total Non-current Assets
999.36MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
190.51MCNYFY2025 · Dec 31, 2025Total Current Liabilities
159.54MCNYFY2025 · Dec 31, 2025Cash
56.98MCNYFY2025 · Dec 31, 2025Cash Equivalents
48.95MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
105.92MCNYFY2025 · Dec 31, 2025Other Short-term Investments
301.22MCNYFY2025 · Dec 31, 2025Accounts Receivable
12.93MCNYFY2025 · Dec 31, 2025Inventory
110.05MCNYFY2025 · Dec 31, 2025Accounts Payable
22.96MCNYFY2025 · Dec 31, 2025Short-term Debt
49.16MCNYFY2025 · Dec 31, 2025Other Current Liabilities
486.04KCNYFY2025 · Dec 31, 2025Long-term Debt
182.81MCNYFY2025 · Dec 31, 2025Common Stock (Book)
401.11MCNYFY2025 · Dec 31, 2025Retained Earnings
440.13MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.41BCNY209.81M · vs all stocks (USD)
Treasury Stock
51.09MCNYFY2025 · Dec 31, 202552-Week Low
5.50CNYUpdated Aug 21, 202652-Week High
8.86CNYUpdated Aug 21, 202652-Week Change
-28.03%vs all stocks
Beta
0.0660xvs all stocks
50-Day MA
6.02CNYUpdated Aug 21, 2026200-Day MA
7.15CNYUpdated Aug 21, 2026Avg 10-Day Volume
2.88MSharesUpdated Aug 21, 2026Avg 30-Day Volume
3.19MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.0900CNYUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How is this stock valued?
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
Where is this company structurally exposed?
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.39Dividend per Share: 0.13Earnings per Share: 0.09
Financial Health
Altman Z-Score 5.38: safe zoneNotable
Altman Z-Score: 5.38
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Kordsa Teknik Tekstil A.S.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
SNT Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kanto Denka Kogyo Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Premier Explosives Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Xinjiang Talimu Agriculture Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Wanxiang Doneed Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Zhejiang Baida Precision Manufacturing Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hubei Guochuang Hi-Tech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
National Fertilizers Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Donglai Coating Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Liaoning Chengda Biotechnology Co., Ltd.
3 interpretationsDown-Close Share With Multi-Year Earnings DecreaseLow-Leverage Liquidity ConfigurationPrice Below Mean With Profitability And Equity
Yangzhou Jinquan Tourism Co., Ltd.
3 interpretationsDown-Close Share With Multi-Year Earnings DecreaseLow-Leverage Liquidity ConfigurationPrice Below Mean With Profitability And Equity
Luyang Energy-saving Materials Co., Ltd.
3 interpretationsDown-Close Share With Multi-Year Earnings DecreaseLow-Leverage Liquidity ConfigurationPrice Below Mean With Profitability And Equity